Contrast Media Injectors

Contrast media injectors are used to injectcontrast mediaor contrast agents to enhance the blood and perfusion in tissues.

EHR screenshot showing sidebar text displayed to referring clinicians after placing orders for body CT (neck, chest, or abdomen and pelvis), describing iohexol shortage and providing appropriate strategies for iodinated contrast media conservation.
News|Contrast Media

August 3, 2022 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), electronic health ...

TimeAugust 03, 2022
arrow
Bracco Diagnostics has announced that the U.S. Food and Drug Administration (FDA) granted import discretion of Iomeron® (iomeprol injection) into the U.S. to address the ongoing iodinated contrast media shortage.
News|Contrast Media

2022年8月2日-随着放射界继续解决供应中断的问题,一项新的更新已宣布……

TimeAugust 02, 2022
arrow
Iodixanol Injection, USP is the first U.S. FDA-approved generic iso-osmolar, dimeric iodinated contrast media agent, which is used during diagnostic x-ray-based imaging such as computed tomography (CT) scans
News|Contrast Media

July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...

TimeJuly 18, 2022
arrow
The global contrast media market is projected to reach $5.9 billion by 2026 from $4.9 billion in 2021, at a CAGR of 3.7% during the forecast period.
Feature|Contrast Media

The global contrast media market is projected to reach $5.9 billion by 2026 from $4.9 billion in 2021, at a CAGR of 3.7% ...

TimeMay 03, 2022
arrow
Lawrence N. Tanenbaum, MD FACR is Vice President/Chief Technology Officer Director of CT, MR, and Advanced Imaging for RadNet with 37+ years experience in the medical field. He is a member of editorial boards of several journals/educational organizations and reviewer for scientific journals. He has authored 100+ scholarly and peer-reviewed articles, chairs educational/academic meetings, and has delivered 2000+ invited global lectures.
Sponsored Content|Case Study|Contrast Media Injectors

产品适应症和用途:克拉里斯康(gadoterate meglamine)是一种基于钆的造影剂,用于…

TimeMay 03, 2022
arrow
NEXO[DOSE] dashboard
Sponsored Content|Blog|Radiation Dose Management

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

TimeApril 11, 2022
arrow
EmpowerMR Injector System
Sponsored Content|Blog|Contrast Media Injectors

Medical imaging and contrast use have become an integral part of the diagnostic process to determine the best ...

TimeFebruary 28, 2022
arrow
Sponsored Content|Blog|Contrast Media Injectors

Patient safety is a fundamental requirement to all applications of radiology techniques and procedures. As the ...

TimeJanuary 21, 2022
arrow
In February 2021, Guerbet announced the launch of OptiProtect 3S (Smart Service Solutions), a range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
Feature|Contrast Media Injectors| By Melinda Taschetta-Millane

Contrast media injectors are used to inject contrast agents to enhance the blood and perfusion in tissues. There have ...

TimeJanuary 19, 2022
arrow
The global contrast media market size is expected to reach USD 7.2 billion by 2028 and is expected to expand at a CAGR of 8.6% from 2021 to 2028.
News|Contrast Media

December 30, 2021 — The "Global Contrast Media Market Size, Share & Trends Analysis Report by Product Type (Iodinated ...

TimeDecember 30, 2021
arrow
Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with the contrast media injectors of ulrich medical, to support the needs of hospitals and imaging networks.
News|Contrast Media Injectors

December 13, 2021 — Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to ...

TimeDecember 13, 2021
arrow
Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes #MRI
News|Contrast Media Injectors

September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthcare ...

TimeSeptember 16, 2021
arrow
Sponsored Content|Blog|Contrast Media Injectors

Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...

TimeApril 29, 2021
arrow
由于慢性疾病发病率和流行率的增加,以及对诊断和介入放射学程序的需求,老龄化人口的增加,造影剂适应症的扩大,新兴市场医学成像的增长,造影剂全球市场预计将在2020年至2027年以高个位数的复合增长率增长,到2027年达到703.35亿美元。increasing research activities and favorable reimbursement
News|Contrast Media

Chemical substances that improve the visibility of specific organs, tissues, or blood vessels during a diagnostic or ...

TimeMay 03, 2021
arrow
Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News|Contrast Media Injectors

February 25, 2021 — Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection ...

TimeFebruary 25, 2021
arrow
斯坦伯格诊断医学影像总部。
Sponsored Content|Case Study|Contrast Media Injectors

Steinberg Diagnostic Medical Imaging (SDMI) was founded 30 years ago and has grown to be one of the largest outpatient ...

TimeJanuary 21, 2021
arrow
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.
Feature|Contrast Media Injectors| By Melinda Taschetta-Millane

According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was ...

TimeJanuary 20, 2021
arrow
This novel agent, based on the essential nutrient manganese, has strong potential as a safer alternative to currently used contrast agents
News|Contrast Media

December 28, 2020 — Adding a contrast-enhancing agent to magnetic resonance imaging (MRI) significantly improves image ...

TimeDecember 28, 2020
arrow
GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent, Clariscan (gadoterate meglumine), in pre-filled syringes. #RSNA20
News|Contrast Media

November 26, 2020 — GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent ...

TimeNovember 26, 2020
arrow
Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging solutions in an immersive digital experience at the first all-virtual Radiological Society of North America (RSNA) annual meeting being held November 29 through December 5.
News|Contrast Media Injectors

November 17, 2020 — Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging ...

TimeNovember 17, 2020
arrow
Subscribe Now